© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
NovaBay Pharmaceuticals, Inc. (NBY) stock declined over -3.59%, trading at $1.88 on AMEX, down from the previous close of $1.95. The stock opened at $1.70, fluctuating between $1.66 and $2.13 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 02, 2026 | 1.58 | 1.98 | 1.57 | 1.95 | 623.93K |
| Apr 01, 2026 | 1.51 | 1.69 | 1.49 | 1.59 | 211.47K |
| Mar 31, 2026 | 1.44 | 1.52 | 1.37 | 1.49 | 246.43K |
| Mar 30, 2026 | 1.44 | 1.50 | 1.33 | 1.35 | 254.79K |
| Mar 27, 2026 | 1.53 | 1.60 | 1.42 | 1.50 | 224.32K |
| Mar 25, 2026 | 1.63 | 1.65 | 1.40 | 1.42 | 377.27K |
| Mar 24, 2026 | 1.40 | 1.75 | 1.27 | 1.50 | 1.2M |
| Mar 23, 2026 | 1.19 | 1.49 | 1.13 | 1.38 | 1.06M |
| Mar 20, 2026 | 1.22 | 1.25 | 1.16 | 1.16 | 128.65K |
| Mar 19, 2026 | 1.25 | 1.28 | 1.15 | 1.22 | 247.3K |
| Mar 18, 2026 | 1.30 | 1.36 | 1.26 | 1.28 | 223.33K |
| Mar 17, 2026 | 1.43 | 1.46 | 1.26 | 1.36 | 430.63K |
| Mar 16, 2026 | 1.23 | 1.85 | 1.22 | 1.45 | 5.46M |
| Mar 13, 2026 | 1.24 | 1.28 | 1.14 | 1.21 | 182.54K |
| Mar 12, 2026 | 1.25 | 1.30 | 1.19 | 1.27 | 215.39K |
| Mar 11, 2026 | 1.24 | 1.36 | 1.20 | 1.27 | 240.65K |
| Mar 10, 2026 | 1.22 | 1.30 | 1.14 | 1.26 | 320.35K |
| Mar 09, 2026 | 1.38 | 1.38 | 1.11 | 1.24 | 501.42K |
| Mar 06, 2026 | 1.50 | 1.60 | 1.35 | 1.39 | 1.29M |
| Mar 03, 2026 | 1.43 | 1.58 | 1.36 | 1.48 | 261.11K |
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
| Employees | 13 |
| Beta | 0.16 |
| Sales or Revenue | $14.73M |
| 5Y Sales Change% | -0.919% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |